GlassScriptPhysician profile
Jennifer K Scranton
NPI 1477129286
$1,870.57
in general payments reported to CMS, 2019-2025
17 companies · $653 in 2025
The $653 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.92 · 2023: $203 · 2024: $979 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.65 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $517.23 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $338.17 | 2023-2025 | |
| Biogen, INC. | $156.94 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $123.21 | 2022-2025 | |
| Astellas Pharma Global Development | $122.05 | 2024 | Veozah |
| Exeltis, USA INC. | $107.79 | 2023-2025 | Slynd |
| Organon LLC | $86.01 | 2024 | |
| Myriad Women'S Health, INC. | $73.72 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $73.59 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $60.31 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $55.07 | 2024-2025 | |
| Daiichi Sankyo INC. | $38.71 | 2024 | Injectafer |
| Sanofi Pasteur INC. | $31.28 | 2024 | |
| Hologic Sales and Service, LLC | $30.51 | 2024 | Acessa Provu System, Coolseal Generator, Omni Hysteroscope |
| Pacira Pharmaceuticals Incorporated | $23.11 | 2025 | Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $19.02 | 2024 | Olympus |
| Novartis Pharmaceuticals Corporation | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Scranton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.